Jump Financial’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
Other funds holding FULC
Jump Financial's FULC Position: Q3 2026 in Review
Jump Financial reduced its Fulcrum Therapeutics (FULC) stake by 57% in Q3 2026, selling an estimated $2.14M and leaving 433,477 shares worth $1.6M. The position accounts for 0.01% of the portfolio, ranked #1145.
Jump Financial first reported a position in FULC in Q2 2021 and has held it in 11 quarters since. The position peaked at $3.68M in Q2 2026. 97 funds tracked by Wall St. Rank hold FULC as of Q3 2026.
- Jump Financial held 433,477 shares of Fulcrum Therapeutics worth $1.6M as of Q3 2026.
- Jump Financial sold 571,523 Fulcrum Therapeutics shares in Q3 2026, an estimated $2.14M.
- Fulcrum Therapeutics made up 0.01% of Jump Financial's portfolio in Q3 2026, its #1145 holding.
- Jump Financial first reported a position in Fulcrum Therapeutics in Q2 2021 and has held it in 11 quarters since.
- Jump Financial's Fulcrum Therapeutics position peaked at $3.68M in Q2 2026.
- 97 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q3 2026.
Based on Jump Financial's 13F filing for Q3 2026, filed 13 Nov 2026.